<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04357405</url>
  </required_header>
  <id_info>
    <org_study_id>2017-A02647-46</org_study_id>
    <nct_id>NCT04357405</nct_id>
  </id_info>
  <brief_title>Study of the Interest of ECG Teletransmission in Retirement Home (EHPAD) In the Ile-de-France Region.</brief_title>
  <acronym>TEECAD</acronym>
  <official_title>Study of the Interest of ECG Teletransmission in Retirement Home (EHPAD) In the Ile-de-France Region.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gérond'if</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gérond'if</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to evaluate the interest and the workability of ECG teletranmission
      in EHPAD in Île-de-France. ECG for the elderly is beneficial to detect or monitor
      cardiovascular disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Main objectives :

        -  Evaluate the workability of ECG uploaded by a caregiver who was trained before

        -  Evaluate the prevalence of ECG anomalies highlighted thanks to the realisation of an
           uploaded ECG (supraventricular and ventricular rhythm disorder and coronary pathology)

      Secondaries objectives :

        -  Evaluate the prevalence of unknown ECG anomalies and thus determine the number of new
           diagnostics highlighted thanks to uploaded ECG

        -  Evaluate the prevalence of ECG iatrogenic anomalies

      The study is observational, multicentre and prospective. It is going to include 3211 elderly
      living in EHPAD in Île-de-France. 150 EHPAD or involved in the study, they are split in two
      groups : 100 EHPAD will receive ECG and 50 EHPAD will not. This last group will enable to
      lead a comparative analysis, only global data about death will be collected.

      The study will last 36 months with 12 months of participation for each resident.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 6, 2019</start_date>
  <completion_date type="Anticipated">July 2022</completion_date>
  <primary_completion_date type="Anticipated">June 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Assessment of teletransmetted electrocardiogram (ECG) feasability (number of ECGs interpretable)</measure>
    <time_frame>12 months</time_frame>
    <description>An interpretable ECG is defined by an absence of parasite, a stable baseline, an absence of argument of a malposition of electrodes, an unwinding paper speed: 25 mm / sec, a calibration of the amplitude</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessment of prevalence of anomalies highlighted by performing an electrocardiogram.</measure>
    <time_frame>12 months</time_frame>
    <description>The prevalence of anomalies highlighted by performing an electrocardiogram: supra-ventricular rhythm disorders, ventricular rhythm disorder and coronary pathologies.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assessment of commorbidity risk and life expectancy according Charlson score.</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of prevalence of unknown and iatrogenic anomalies according to the electrocardiogram</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">3211</enrollment>
  <condition>Cardiac Pathology</condition>
  <condition>Residents of Retirement Home (EHPAD)</condition>
  <arm_group>
    <arm_group_label>Experimental arm</arm_group_label>
    <description>This group consists of 100 EHPAD which will benefit from ECG teletransmission. all data will be collected</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control arm</arm_group_label>
    <description>This arm consists of 50 EHPAD that have not benefited from ECG teletransmission. Only the global death occurrence data will be analyzed, no individual data will be collected.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients living in nursing homes (EHPAD) requiring an electrocadiogram (ECG) except
        emergency situation, due to a cardiac pathology with / or without treatment which can lead
        to ECG abnormalities
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Elderly living in nursing homes (EHPAD) who requires electrocadiogram (ECG) due to :

          -  Cardiac pathology : coronary artery disease, heart failure, high blood pressure,
             diabetes, valvular disease, atrial fibrillation

          -  A medication which could causes electrocadiogram (ECG) anomalies Patients living in
             nursing homes (EHPAD) who give their agreement.

        Exclusion criteria :

        Protected adult under a protection of the court
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Olivier Hanon, MD PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Psychiatric Geriatric Department, Broca hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Isabelle Dufour</last_name>
    <phone>+33 (0) 185781010</phone>
    <email>isabelle.dufour@gerondif.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Margot Bobin</last_name>
    <phone>+33 (0) 185781010</phone>
    <email>margot.bobin@gerondif.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Psychiatric Geriatric Department, Broca hospital</name>
      <address>
        <city>Paris</city>
        <state>Ile-de-France</state>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>+33(0) 144083000</phone>
      <email>olivier.hanon@aphp.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 16, 2020</study_first_submitted>
  <study_first_submitted_qc>April 21, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 22, 2020</study_first_posted>
  <last_update_submitted>April 23, 2020</last_update_submitted>
  <last_update_submitted_qc>April 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ECG</keyword>
  <keyword>Elderly EHPAD's resident</keyword>
  <keyword>Cardiac desease</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

